| Bruce Sheade, MD | |
|
300 1st Capitol Dr, Saint Charles, MO 63301-2844 | |
| (314) 989-3000 | |
| Not Available |
| Full Name | Bruce Sheade |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 300 1st Capitol Dr, Saint Charles, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659355303 | NPI | - | NPPES |
| 050028633 | Other | MO | RR MEDICARE |
| 203718101 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 102741 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm St Joseph Hospital West | Lake saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metro-west Anesthesia Group Inc | 2163329921 | 157 |
News Archive
Celldex Therapeutics, Inc. today announced that interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer will be presented in a webcast on May 23, 2012. Linda Vahdat, MD, Professor of Medicine, Chief of Solid Tumor Service and Director of the Breast Cancer Research Program at Weill Cornell Medical College and the lead investigator of the EMERGE study, will join Celldex on the webcast to discuss data from the study.
A new study suggests that eating breakfast as part of a diet could actually lead to weight gain, rather than weight-loss!
A novel strategy for circumventing safety problems that have plagued gene therapy has been offered by a complex multicenter group of researchers, including Professor Claudio Napoli, a Full Professor at the II University of Naples and Adjunct Professor at the Sbarro Research Institute for Cancer Research and Molecular Medicine and the Center of Biotechnology at the College of Science and Technology of Temple University.
Signals can tell cells to act cancerous, surviving, growing and reproducing out of control. And signals can also tell cells with cancerous characteristics to stop growing or to die. In breast cancer, one tricky signal called TGF-beta does both - sometimes promoting tumors and sometimes suppressing them.
A team of researchers from the Federal University of Health Sciences of Porto Alegre and the Federal University of Rio Grande do Sul performed a systematic review to assess these population-based COVID-19 prevalence surveys' reliability and biases qualitatively. Their study is published on the preprint server medRxiv.
› Verified 3 days ago
| Entity Name | Metro-west Anesthesia Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245427335 PECOS PAC ID: 2163329921 Enrollment ID: O20031219000779 |
News Archive
Celldex Therapeutics, Inc. today announced that interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer will be presented in a webcast on May 23, 2012. Linda Vahdat, MD, Professor of Medicine, Chief of Solid Tumor Service and Director of the Breast Cancer Research Program at Weill Cornell Medical College and the lead investigator of the EMERGE study, will join Celldex on the webcast to discuss data from the study.
A new study suggests that eating breakfast as part of a diet could actually lead to weight gain, rather than weight-loss!
A novel strategy for circumventing safety problems that have plagued gene therapy has been offered by a complex multicenter group of researchers, including Professor Claudio Napoli, a Full Professor at the II University of Naples and Adjunct Professor at the Sbarro Research Institute for Cancer Research and Molecular Medicine and the Center of Biotechnology at the College of Science and Technology of Temple University.
Signals can tell cells to act cancerous, surviving, growing and reproducing out of control. And signals can also tell cells with cancerous characteristics to stop growing or to die. In breast cancer, one tricky signal called TGF-beta does both - sometimes promoting tumors and sometimes suppressing them.
A team of researchers from the Federal University of Health Sciences of Porto Alegre and the Federal University of Rio Grande do Sul performed a systematic review to assess these population-based COVID-19 prevalence surveys' reliability and biases qualitatively. Their study is published on the preprint server medRxiv.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bruce Sheade, MD 13523 Barrett Parkway Dr, Suite 210, Ballwin, MO 63021-3802 Ph: (314) 775-2816 | Bruce Sheade, MD 300 1st Capitol Dr, Saint Charles, MO 63301-2844 Ph: (314) 989-3000 |
News Archive
Celldex Therapeutics, Inc. today announced that interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer will be presented in a webcast on May 23, 2012. Linda Vahdat, MD, Professor of Medicine, Chief of Solid Tumor Service and Director of the Breast Cancer Research Program at Weill Cornell Medical College and the lead investigator of the EMERGE study, will join Celldex on the webcast to discuss data from the study.
A new study suggests that eating breakfast as part of a diet could actually lead to weight gain, rather than weight-loss!
A novel strategy for circumventing safety problems that have plagued gene therapy has been offered by a complex multicenter group of researchers, including Professor Claudio Napoli, a Full Professor at the II University of Naples and Adjunct Professor at the Sbarro Research Institute for Cancer Research and Molecular Medicine and the Center of Biotechnology at the College of Science and Technology of Temple University.
Signals can tell cells to act cancerous, surviving, growing and reproducing out of control. And signals can also tell cells with cancerous characteristics to stop growing or to die. In breast cancer, one tricky signal called TGF-beta does both - sometimes promoting tumors and sometimes suppressing them.
A team of researchers from the Federal University of Health Sciences of Porto Alegre and the Federal University of Rio Grande do Sul performed a systematic review to assess these population-based COVID-19 prevalence surveys' reliability and biases qualitatively. Their study is published on the preprint server medRxiv.
› Verified 3 days ago
John Gisi, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 1st Capitol Dr, Saint Charles, MO 63301 Phone: 314-989-3000 | |
Gregg Bantrup, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 1st Capitol Dr, Saint Charles, MO 63301 Phone: 314-989-3000 | |
Stephanie J Sellner, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 First Capitol Drive, Ste 210, Saint Charles, MO 63301 Phone: 314-775-2816 | |
Gregory J Macdonnell, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5 Glenview Dr, Saint Charles, MO 63304 Phone: 636-244-4666 | |
Willard Chamberlin, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 1st Capitol Dr, Saint Charles, MO 63301 Phone: 314-989-3000 | |
Lawrence Baudendistel, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 300 1st Capitol Dr, Saint Charles, MO 63301 Phone: 314-989-3000 |